these patients in order to use these lymphocytes for adoptive immunotherapy as 
detailed in previous protocols. The direct effect of the immunization with these 
immunogenic tumor cells will also be measured by assessing the impact on established 
tumor at other sites. Fifty patients receiving tumor inoculation will be included in 
this study. 
I 
i 
[104] 
Recombinant DNA Research, Volume 15 
